House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.
HHS Inspector General Probes Potential Financial Conflicts By NIH Grantees.
Cancer Biomarker Research “Piecemeal and Unorganized,” IOM Report Finds.
Physicians Group Makes No “Simple Recommendation” on Mammograms for Women Aged 40-49.
Trending Stories
- “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process - DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions
- How City of Hope is turning microbiome science into better cancer care
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - FDA clears fruit-flavored vapes, relaxes enforcement on black-market products with pending premarket applications
Critics say policies clear the way for major tobacco companies to enter fruit-flavored vape market - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members









